Document Type

Article

Publication Date

2013

Publication Title

Blog: Science and Industry

Abstract

Human Genome Sciences (HGS) was not a company with normal ambitions. At its inception, HGS aspired to dominate not only the field of genomic science, but also emerging markets for regenerative medicines designed to meet the needs of ageing populations. Fred Ledley asks whether HGS could have become the Standard Oil of our generation.

Comments

Originally published on scienceandindustry.org

Download

Share

COinS